EVP-6124 (Alpha-7 nAChR) for schizophrenia
This study is completed in the United States, in Australia, in Canada, .... It is testing EVP-6124 (Alpha-7 nAChR) for schizophrenia.
In United States
Compare studies and check their requirements with the research team.
This study is completed in the United States, in Australia, in Canada, .... It is testing EVP-6124 (Alpha-7 nAChR) for schizophrenia.
In United StatesThis study is completed in the United States. 6 mg Taken Daily at Bedtime for PTSD.
In United StatesThis study is completed in the United States and in Israel. It is testing MG01CI 1400 mg Compared With Placebo for ADHD.
In United StatesThis EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study is completed in the United States. It is testing 21 Milligram (mg) Nicotine Transdermal Patches (NicoDerm CQ, GlaxoSmithKline [GSK] Dungarvan) Compared to the Current Marketed 21 mg Nicotine Transdermal Patches (NicoDerm CQ, Alza) for Addiction.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study is completed in the United States and in Canada. It is testing liafensine for Depression.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.